Keevil Brian G, Tierney David P, Cooper Donald P, Morris Michael R, Machaal Ali, Yonan Nizar
Department of Clinical Biochemistry, Wythenshawe Hospital, Manchester, United Kingdom.
Ther Drug Monit. 2002 Dec;24(6):757-67. doi: 10.1097/00007691-200212000-00013.
A simple and rapid liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the simultaneous analysis of cyclosporin A (CsA) and creatinine using capillary blood has been developed. Venous and capillary blood samples were taken predose and at C2 from 65 heart and lung transplant recipients (65 x 4 samples). For comparisons, serum creatinine and blood CsA concentrations were measured by the Jaffe and EMIT methods, respectively, using an Olympus AU600 analyzer. For the LC-MS/MS assay, samples were prepared in a 96 x 700-microL well block by adding 10 microL of blood (or serum) to 40 microL of 0.1 mol/L zinc sulphate solution containing deuterated creatinine internal standard. Proteins were precipitated by adding 100 microL acetonitrile containing ascomycin internal standard. After vigorous mixing and centrifugation, 5 microL of the supernatant was injected into the LC-MS/MS system. A Waters 2795 high-performance liquid chromatography (HPLC) system was used to elute a C18 cartridge (3 mm x 4 mm) at 0.6 mL/min with a step gradient of 50-100% methanol containing 2 mmol/L ammonium acetate and 0.1% (v/v) formic acid. The column was maintained at 55 degrees C, and the retention times were creatinine, 0.4 minutes; ascomycin, 0.98 minutes; and CsA, 1.2 minutes. Cycle time was 2.5 minutes, injection to injection. The analytes were monitored using a Quattro microtandem mass spectrometer operated in multiple reaction monitoring mode using the following transitions: creatinine, m/z 114>44; d3-creatinine (IS), m/z 117>47; ascomycin (IS), m/z 809>756; and CsA, m/z 1,220>1,203. Assay characteristics were CsA intraassay CV, 3.6-3.0% (33-1,500 microg/L); CsA interassay CV, 6.7-2.5% (10-5,000 microg/L); LC-MS/MS capillary [CsA] = 0.99 x LC-MS/MS venous [CsA] - 4.2, R = 0.98; and LC-MS/MS venous [CsA] = 0.93 x EMIT venous [CsA] + 2.9, R = 0.98. Creatinine intraassay CV, 6.6-2.5% (20-720 micromol/L); interassay CV, 5.7-3.3% (80-590 micromol/L); LC-MS/MS capillary [creatinine] = 0.99 Jaffe plasma [creatinine] -42.6, R = 0.87. Total time for the preparation and analysis of 30 samples was approximately 2 hours. This assay will provide a flexible, robust, and cost-effective solution for the monitoring of CsA and creatinine in transplant recipients with potential applications in pediatric medicine and pharmacokinetic studies, in which frequent sampling is required.
已开发出一种简单快速的液相色谱串联质谱法(LC-MS/MS),用于同时分析环孢素A(CsA)和肌酐,采用的是毛细血管血样。对65例心肺移植受者在给药前及C2时间点采集静脉血和毛细血管血样本(65×4份样本)。为作比较,分别使用奥林巴斯AU600分析仪,通过Jaffe法和EMIT法测定血清肌酐和血液中CsA浓度。对于LC-MS/MS测定,在96孔、700微升的孔板中制备样本,向含有氘代肌酐内标的40微升0.1摩尔/升硫酸锌溶液中加入10微升血液(或血清)。加入含有子囊霉素内标的100微升乙腈使蛋白质沉淀。剧烈混合并离心后,将上清液5微升注入LC-MS/MS系统。使用沃特世2795高效液相色谱(HPLC)系统,以0.6毫升/分钟的流速洗脱C18柱(3毫米×4毫米),流动相为含2毫摩尔/升醋酸铵和0.1%(v/v)甲酸的50 - 100%甲醇,采用梯度洗脱。柱温保持在55℃,保留时间分别为:肌酐0.4分钟;子囊霉素0.98分钟;CsA 1.2分钟。进样周期为2.5分钟。使用Quattro micro串联质谱仪在多反应监测模式下监测分析物,采用以下离子跃迁:肌酐,m/z 114>44;d3 - 肌酐(内标),m/z 117>47;子囊霉素(内标),m/z 809>756;CsA,m/z 1220>1203。分析方法特性为:CsA批内变异系数(CV),3.6 - 3.0%(33 - 1500微克/升);CsA批间CV,6.7 - 2.5%(10 - 5000微克/升);LC-MS/MS法测定的毛细血管血中[CsA] = 0.99×LC-MS/MS法测定的静脉血中[CsA] - 4.2,R = 0.98;LC-MS/MS法测定的静脉血中[CsA] = 0.93×EMIT法测定的静脉血中[CsA] + 2.9,R = 0.98。肌酐批内CV,6.6 - 2.5%(20 - 720微摩尔/升);批间CV,5.7 - 3.3%(80 - 590微摩尔/升);LC-MS/MS法测定的毛细血管血中[肌酐] = 0.99×Jaffe法测定的血浆中[肌酐] - 42.6,R = 0.87。30个样本的制备和分析总时间约为2小时。该分析方法可为移植受者中CsA和肌酐的监测提供一种灵活、可靠且经济高效的解决方案,在儿科医学和药代动力学研究中有潜在应用,因为这些研究需要频繁采样。